Company Filing History:
Years Active: 2007-2009
Title: Friedhelm Hildebrandt: Innovator in Nucleic Acids and Proteins
Introduction
Friedhelm Hildebrandt is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of molecular biology, particularly in the study of nucleic acids and proteins related to kidney diseases. With a total of two patents to his name, his work has implications for understanding and diagnosing genetic disorders.
Latest Patents
Hildebrandt's latest patents include innovations related to Nephronophthisis and Barttin. The first patent, titled "NPHP nucleic acids and proteins," focuses on the NPHP5 protein, also known as nephrocystin-5. This invention provides assays for detecting NPHP5 polymorphisms and mutations associated with various disease states. The second patent, "BSND nucleic acids and proteins," pertains to the BSND protein and its encoding nucleic acids. This invention also offers assays for the detection of BSND and Barttin polymorphisms and mutations linked to disease conditions.
Career Highlights
Hildebrandt is affiliated with the University of Michigan, where he conducts research and develops his innovative ideas. His work has garnered attention in the scientific community, contributing to advancements in genetic research and diagnostics.
Collaborations
Throughout his career, Hildebrandt has collaborated with esteemed colleagues, including Edgar A Otto and Hemant Khanna. These partnerships have enhanced the scope and impact of his research.
Conclusion
Friedhelm Hildebrandt's contributions to the field of molecular biology through his patents on nucleic acids and proteins are invaluable. His work continues to influence the understanding of genetic disorders and their associated mutations.